TLDR: A $3000 ventilator was βon schedule to file for market approval in September 2013β and then Covidien bought out the competition to prevent it coming to fruition.
Covidien at the time already sold a $5000 portable ventilator, which was never rejected by the FDA. The prospective Newport ventilator was rejected for neonatal use, which was a requirement of their BARDA contract.
https://www.nytimes.com/2020/03/29/business/coronavirus-us-v...
TLDR: A $3000 ventilator was βon schedule to file for market approval in September 2013β and then Covidien bought out the competition to prevent it coming to fruition.